switching between glp-1 agonists ada #4 NN Clinical Use Switching Between Glucagon-Like Peptide-1 Receptor
Description
At 48 weeks, the mean relative change from baseline in liver fat was 51.3% (1 mg), 59.0% (4 mg), 81.7% (8 mg), 86.0% (12 mg), and 4.6% (placebo)
[DOI] [PubMed] [Google Scholar] 173.Nahra R., Wang T., Gadde K.M., Oscarsson J., Stumvoll M., Jermutus L., Hirshberg B., Ambery P
How to Get in Touch with Pritikin For those interested in learning more about how Pritikin can support their weight loss journey with GLP-1 or GIP medications, detailed information is available on the Pritikin website
GLP-1RAs (Glucagon-like peptide 1 receptor agonists) benefit not only blood sugar but obese and related metabolic disorders
